NoBoCap Final Investors’ Webinar: From Certification to Capital!
For Europe’s MedTech start-ups and SMEs, a CE certificate under the MDR or IVDR has become a question of survival, not only compliance. Notified-body timelines, clinical-evidence costs and regulatory changes determine when a product reaches the market, and investors price every one of them.
NoBoCap has worked to increase notified-body capacity and help manufacturers become better prepared through training, e-tools and structured dialogue between notified bodies, regulators and industry.
Through training, e-tools and structured dialogue between notified bodies, regulators and industry, NoBoCap has worked to increase notified body capacity and help manufacturers become better prepared.
Our final investors’ webinar connects regulatory readiness with access to capital, exploring what certification means to investors and how companies can turn a solid certification pathway into a stronger investment case.
Investors, innovators, the NoBoCap Community and experts in HTA, remote health and digital innovation will discuss:
🔹 From certification to market readiness: notified-body capacity, HTA evidence, validation at scale and digital innovation support.
🔹 Regulatory risk: how investors assess regulatory challenges during due diligence.
🔹 Funding opportunities: which public and private funding routes fit each stage of certification.
📅 23 November 2026
🕒 15:00–17:00 CET
💻 Online
🔗 Register now: https://short.do/DjtT8t








